Vincent Laudone
Perspective
By Vincent Laudone, MD, Co-Director for Robotic Surgery  |  Tuesday, March 4, 2014

Our conversation about active surveillance of prostate cancer continues. Let’s take a closer look at our protocols for selecting and monitoring patients.

Pictured: Low-dose CT scans
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 26, 2013

The American Society of Clinical Oncology’s annual report on top clinical cancer advances of the year once again features several studies led by Memorial Sloan Kettering researchers.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 12, 2013

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Michael Zelefsky
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, October 23, 2013

Memorial Sloan Kettering offers patients with prostate cancer a comprehensive package of the most advanced radiation therapy approaches that enable more-personalized and effective care.

Pictured: Vincent Laudone and James Eastham
Perspective
By James Eastham, MD and Vincent Laudone, MD
Friday, September 20, 2013

An earlier post about active surveillance as a management strategy for prostate cancer generated an engaged and meaningful discussion on this blog, especially about the risks of “doing nothing.” Here we take a closer look at the concept of risk.

Pictured: Vincent Laudone  & James Eastham
Perspective
By James Eastham, MD and Vincent Laudone, MD
Wednesday, August 14, 2013

Active surveillance is the most appropriate management strategy for many men with prostate cancer, but often this option is never mentioned.

Pictured: Pramod Sogani
Honor
By Media Staff  |  Monday, July 1, 2013

Memorial Sloan Kettering urologic surgeon Pramod Sogani has been inaugurated as President of the American Urological Association. In this Q&A he discusses his goals and his new role.

Charles Sawyers, Kenneth Offit, and Larry Norton
Honor
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, May 22, 2013

Charles Sawyers, Larry Norton, and Kenneth Offit are being honored with special awards at the annual meeting of the world’s leading professional organization for cancer physicians and researchers.

Pictured: Charles Sawyers
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Pictured: Andrew Vickers
Finding
By Allyson Collins, MS, Science Writer/Editor  |  Wednesday, April 17, 2013

A study led by Memorial Sloan Kettering investigators indicates nearly half of all prostate cancer deaths by age 75 occur in a small group of men with high PSA levels at age 45.

Pictured: Peter Scardino
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, March 14, 2013

Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.

Pictured: John Mulhall
Q&A
By Media Staff  |  Friday, March 8, 2013

Dr. Mulhall, director of Memorial Sloan Kettering’s Male Sexual and Reproductive Medicine Program, explains common concerns about male sexual health and offers advice for men and their partners.

Pictured: Raul Parra
Video
By Memorial Sloan Kettering  |  Wednesday, March 6, 2013

Dr. Parra, who practices at Memorial Sloan Kettering Basking Ridge, treats prostate, kidney, and bladder cancers with the goal of extending the lives of patients, and giving them the best possible quality of life.

Pictured: David Finley & Maria Teresa Ruiz Tsukazan
Feature
By Celia Gittelson, BA  |  Monday, February 25, 2013

Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.

Pictured: Charles Sawyers
Honor
By Media Staff  |  Wednesday, February 20, 2013

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Center News

Stay Informed

Get the latest information about cancer care and research every month.